Inspire Medical Systems logged a 0.9% change during today's morning session, and is now trading at a price of $179.71 per share.
Inspire Medical Systems returned losses of -30.4% last year, with its stock price reaching a high of $330.0 and a low of $123.27. Over the same period, the stock underperformed the S&P 500 index by -46.6%. As of April 2023, the company's 50-day average price was $153.73. Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. Based in Golden Valley, MN, the mid-cap Health Care company has 755 full time employees. Inspire Medical Systems has not offered a dividend during the last year.
Growing Revenues With Increasing Reinvestment in the Business:
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Revenue (k) | $50,593 | $82,050 | $115,381 | $233,394 | $407,856 | $570,191 |
| Revenue Growth | n/a | 62.18% | 40.62% | 102.28% | 74.75% | 39.8% |
| Operating Margins | -40% | -40% | -49% | -17% | -11% | -6% |
| Net Margins | -43% | -41% | -50% | -18% | -11% | -6% |
| Net Income (k) | -$21,828 | -$33,243 | -$57,203 | -$42,042 | -$44,881 | -$32,766 |
| Net Interest Expense (k) | $3,304 | $2,119 | $2,117 | $2,128 | $3,324 | $18,032 |
| Depreciation & Amort. (k) | $568 | $495 | $840 | $1,218 | $1,858 | $2,598 |
| Free Cash Flow (k) | -$18,944 | -$35,585 | -$55,500 | -$24,787 | $2,473 | $8,109 |
| Capital Expenditures | $250 | $2,739 | $2,455 | $4,668 | $9,096 | $18,546 |
| Current Ratio | 17.86 | 10.12 | 13.02 | 6.5 | 8.66 | 8.14 |
| Total Debt (k) | $24,825 | $24,472 | $30,632 | $33,783 | $7,536 | $25,173 |
Inspire Medical Systems does not have a meaningful trailing P/E ratio since its earnings per share are negative. Its forward EPS guidance is negative too, at $-0.68. The average P/E ratio for the Health Care sector is 30.21. Furthermore, Inspire Medical Systems is likely overvalued compared to the book value of its equity, since its P/B ratio of 9.71 is higher than the sector average of 4.08.
Analysts Give Inspire Medical Systems an Average Rating of Buy:
The 12 analysts following Inspire Medical Systems have set target prices ranging from $180.0 to $250.0 per share, for an average of $215.25 with a buy rating. As of April 2023, the company is trading -28.6% away from its average target price, indicating that there is an analyst consensus of some upside potential.
Inspire Medical Systems has an average amount of shares sold short because 3.9% of the company's shares are sold short. Institutions own 98.4% of the company's shares, and the insider ownership rate stands at 1.6%, suggesting a small amount of insider investors. The largest shareholder is Vanguard Group Inc, whose 10% stake in the company is worth $541,365,197.
